Healthcare
Live Price
Offline$1.29
-5.15% today
Window Change
+0.00%
Window
Jun 23, 2025 → Jul 16, 2025
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 17 bars · Jun 23, 2025 → Jul 16, 2025
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Akoya Biosciences, Inc. (AKYA) is a Healthcare stock with a market cap of $64.44M. The stock last traded around $1.29 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jul 16, 2025). Baseline metrics include revenue growth of -15.5%, EPS growth of +21.7%, a dividend yield of 0.0%. What stands out right now is revenue -15.5%, EPS +21.7%, free cash flow +14.7% with operating margin -50.3% and ROIC -22.7%. Valuation is more restrained than many high-expectation growth names at price/sales 1.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines AKYA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
AKYA
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
AKYA Max Drawdown
-6.77%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for AKYA and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.